| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.53 | 9e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |